Molecular Crosstalk Between Vitamin D and Non-Alcoholic Fatty Liver Disease (NAFLD):Unveiling Revolutionary Insights”

Molecular-Crosstalk-Between-Vitamin-D-and-Non-Alcoholic-Fatty-Liver-Disease

Molecular Crosstalk Between Vitamin D and Non-Alcoholic Fatty Liver Disease (NAFLD) Non-alcoholic fatty liver disease (NAFLD) has become a significant public health concern, affecting millions worldwide. It ranges from simple steatosis (fat accumulation in the liver) to non-alcoholic steatohepatitis (NASH), which can progress to cirrhosis and liver cancer. Understanding the molecular mechanisms underlying NAFLD is … Read more

Response to Immunotherapy Linked with Improved Liver Function in Advanced Hepatocellular Carcinoma (HCC)

Liver function

Response to Immunotherapy Linked with Improved Liver Function in Advanced Hepatocellular Carcinoma (HCC) Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, poses significant treatment challenges, especially in its advanced stages. Traditional treatment options such as surgery, chemotherapy, and targeted therapy often fall short, leaving patients with limited hope for improved outcomes. However, … Read more

Antiviral Medications that Treat Hepatitis C Improve Long-Term Outcomes

HEPATITIS C TREATED WITH ANTIVIRAL MEDICATION

Antiviral Medications that Treat Hepatitis C Improve Long-Term Outcomes Introduction Defining Hepatitis C Hepatitis C is a viral infection that causes inflammation of the liver, potentially leading to serious liver damage over time. It is caused by the Hepatitis C virus (HCV), which is transmitted through contact with contaminated blood. Overview of Antiviral Medications Antiviral … Read more